Chimeric Therapeutics (ASX:CHM) Advances Phase 1B AML Trial
Chimeric Therapeutics (ASX:CHM) advances its ADVENT-AML Phase 1B trial for newly diagnosed AML patients.
Chimeric Therapeutics (ASX:CHM) advances its ADVENT-AML Phase 1B trial for newly diagnosed AML patients.
Ausgold Limited reports promising gold intercepts from drilling at its Katanning Gold Project.
American West Metals Limited (ASX: AW1) announces a 117% increase in the Indicated Mineral Resource Estimate for the Storm Copper Project.
Eagle Mountain Mining Limited (ASX:EM2) announces a renounceable entitlement issue aiming to raise A$6.4 million for exploration and debt reduction.
Cobram Estate Olives Limited reports a successful US harvest, significant grove expansion, and strong sales performance across markets.
Mineral Commodities Ltd (ASX:MRC) has agreed to sell the Skaland Graphite Project for USD$11.75 million to strengthen its financial position.
BPH Global has secured A$125,000 through a private placement to advance its Indonesian seaweed venture.
Rimfire Pacific Mining (ASX:RIM) reveals high-grade scandium drilling results, advancing towards a Mineral Resource estimate at Murga.
Artemis Resources Limited secures A$4 million to fund drilling at its Karratha Gold Project, set to commence early in 2025.
Javelin Minerals completes its Phase 1 drilling program at Coogee, with results expected shortly and future drilling planned.